Novartis is delighted that the National Institute of Health and Care Excellence (NICE) has recommended Xolair® (omalizumab) as an option for add-on therapy for treating severe CSU for adults...
Tissue Regenix Group plc, the regenerative medical devices company, today announces its DermaPure® dermal allograft has received notice of Local Coverage Determination (LCD) from the Medicare...
Bruin Biometrics LLC, a medical technology company employing biometric sensors for earlier, more accurate detection of chronic, preventable conditions flagged by policy makers as high-priority has...
Myriad Genetics, Inc. has announced the Journal of Cutaneous Pathology published data from a pivotal clinical validation study that showed the myPath Melanoma test is highly effective at...
Among melanoma patients who were treated with immunotherapies, those whose tumors had mutations in the gene NRAS had better response and treatment outcomes than those whose tumors did not have NRAS...
Cells control the adhesion protein desmoplakin by modifying the tail end of the protein, and this process goes awry in some patients with arrhythmogenic cardiomyopathy, according to a study in The...
A team of European researchers has devised a strategy to ensure that adult epidermal stem cells are safe before they are used as treatments for patients.
Immunotherapy with natural signaling substance relieves skin conditionA three-character code brings relief to patients with psoriasis and sheds light on complex immunoregulation processes: IL-4...
The American College of Physicians (ACP) has published two evidence-based clinical practice guidelines in Annals of Internal Medicine for the prevention and treatment of bedsores, also called...
People with psoriasis and their health care providers will have the opportunity to participate in research that aims to improve treatments and disease outcomes when the first independent U.S.